Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

A Phase I/II Trial to Evaluate the Safety and Efficacy of SOT102 as Monotherapy and in Combination With Standard of Care Treatment in Patients With Pancreatic Adenocarcinoma

Summary

The purpose of this phase I/II trial is to evaluate the safety and feasibility of SOT102 in combination with gemcitabine and nab-paclitaxel in patients with locally advanced or metastatic pancreatic cancer.

General Information

NCT#: NCT05525286
Study ID: SN201
Trial Phase: Phase I/II

Trial Sponsor: SOTIO Biotech
Therapies Used in This Trial: Nab-paclitaxel, Gemcitabine, SOT102

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search